Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy premenopausal women: Relationship with body weight regulation

Pharmacopsychiatry

Volumn 30, Issue 6, 1997, Pages 256-262

  Baptista, T ^a,d   Molina, M G ^a   Martinez, J L ^b   De Quijada, M ^a   Calanche De Cuesta, I ^c   Acosta, A ^b   Paez X ^a   Martinez, J M ^a   Hernandez L ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

^b Medical School

^c Dentistry School

^d NONE   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; INSULIN; PLACEBO; PROGESTERONE; PROLACTIN; SULPIRIDE; TESTOSTERONE; THYROTROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOCRINE DISEASE; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPERPROLACTINEMIA; LIPID BLOOD LEVEL; NORMAL HUMAN; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; WEIGHT GAIN;

EID: 0031466675     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979503     Document Type: Article

References (55)

1. Aso, T., M. Matsouka, J. Su, K. Horie, S. Taii, T. Motohashi, T. Nishimura: Influence of sulpiride-induced hyperprolactinemia on baboon menstrual cycles: a longitudinal study. J. med. Primatol. 11 (1982) 20-34
2. Ataya, K., A. Mercado, J. Kartaginer, J. Abbasi, K. S. Moghissi: Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia. Fertil. & Steril. 50 (1988) 876-881
3. Baldessarini, R. J: Drugs and the treatment of psychiatric disorders: psychosis and anxiety. In: Hardman, J. G., E. Limbird, P. B. Molinoff, R. W. Ruddon, A. Goodman Gilman: Goodman & Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill, New York (1996) 399-427
4. Bhavnani, S. M., G. M Levin: Antipsychotic agents: a survey of the prevalence, severity and burden of side effects. Int. Clin. Psychopharmacol. 11 (1996) 1-12
5. 2 dopamine receptors involved? Pharmacol. Biochem. Behav. 27 (1987) 399-405
6. Baptista, T., M. A. Parada, E. Murzi: Puberty modifies sulpiride effects on body weight in rats. Neurosci. Lett. 92 (1988) 161-164
7. Baptista, T., L. Hernández, B. G. Hoebel: Systemic sulpiride increases dopamine metabolites in the lateral hypothalamus. Pharmacol. Biochem. Behav. 37 (1990) 227-229
8. Baptista, T., E. Uzcategui: Substance use among resident doctors in Venezuela. Drug & Alcoh. Depend. 32 (1993) 127-132
9. Baptista, T., L. Teneud, Q. Contreras, T. Alastre, J. L. Burguera, M. de Burguera, E. de Baptista, S. R. B. Weiss, L. Hernández: Lithium and body weight gain. Pharmacopsychiat. 28 (1995) 35-44
10. Baptista, T., D. Reyes, L. Hernández: Reproductive hormones in psychiatric patients under long-term antipsychotic treatment: relatioship with body weight regulation. 27th Neuroscience Annual Meeting, New Orleans, (1997a, in press)
11. Baptista, T., M. A. López, L. Teneud, Q. Contreras, T. Alastre, M. Quijada, X. Páez, S. R. B. Weiss, E. Musseo, L. Hernández: Amantadine in the treatment of neuroleptic-induced obesity in female rats: behavioral, endocrine and neurochemical correlates. Pharmacopsychiat. 30 (1997b) 43-54
12. Baptista, T., E. Araujo de Baptista, S. R. B. Weiss, L. Hernández, M. Altemus: Tamoxifen prevents sulpiride-induced obesity in female rats. Pharmacol. Biochem. Behav. 56 (1997c) 215-222
13. Bech, P., M. Kastrup, O. J. Rafaelsen: Mini-compendium of rating scales of anxiety, depression, mania and schizophrenia, with corresponding DSM-III syndromes. Acta Psychiatr. Scand. 326 (1986) (Suppl.) 7-36
14. Beck, P.: Contraceptive steroids: modifications of carbohydrate and lipid metabolism. Metabolism 22 (1973) 841-855
15. Besser, G. M., M. O. Thorner: Prolactin and gonadal function. Pathol. Biol. (Paris) 23 (1975) 779-782
16. Beumont, P. J. V., J. Bergen: Neuroendocrine effects of neuroleptics. In: Beumont, P. J. V. and G. H. Burrows (Eds.): Handbook of psychiatry and endocrinology. Elsevier Biomedical Press, Amsterdam (1982) pp. 157-174
17. Björntorp, P.: Endocrine abnormalities of obesity. Metabolism 44 (1995) 21-23 (suppl.)
18. Cabrera, R., P. Mayor, J. Fernández-Ruiz, C. Calle: Insulin binding and action on adipocytes from female rats with experimentally induced chronic hyperprolactinemia. Mol. Cell Endocrinol. 58 (1988) 167-173
19. Claus, A., J. Bollen, H. De Cuyper, M. Eneman, M. Malfroid, J. Peuskene, S. Heylen: Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study. Acta Psychiat. Scand. 85 (1992) 295-305
20. Correa, N., L. A. Opler, S. R. Kay, B. Birmaher: Amantadine in the treatment of neuroendocrine side effects of neuroleptics. J. Clin. Psychopharmacol. 7 (1987) 91-95
21. Creemers, L. B., P. M. J. Zelissen, J. W. van't Verlaat, H. P. F. Koppeschaar: Prolactinoma and body weight: a retrospective study. Acta Endocrinol. 125 (1991) 293-296
22. Demura, R., M. Ono, H. Demura, K. Shizume, H. Oouchi: Prolactin directly inhibits basal as well as gonadotropin-stimulated secretion of progesterone and 17β-estradiol in the human ovary. J. Clin. Endocrinol. Metab. 54 (1982) 1246-1250
23. Dorrington, J., R. E. Gore-Langton: Prolactin inhibits oestrogen synthesis in the ovary. Nature 290 (1981) 600-602
24. Ebeling, P., V. A. Koivisto: Physiological importance of dehydroepiandrosterone. Lancet 343 (1994) 1479-1481
25. Erle, G., M. Basso, G. Federspil, N. Sicolo, C. Scandellari: Effect of chlorpromazine on blood glucose and plasma insulin in man. Eur. J. Clin. Pharmacol. 11 (1977) 15-18
26. Felber, J. P., E. Haesler, E. jéquier: Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin dependent) diabetes mellitus. Diabetol. Rev. 36 (1993) 1221-1229
27. Ferreira, M. F., L. G. Sobrinho, J. S. Pires, M. E. S. Silva, M. A. Santos, M. F. F. Santos: Endocrine and psychological evaluation of women with recent weight gain. Psychoneuroendocrinol. 20 (1995) 53-63
28. Gerardo-Gettens, T., B. J. Moore, J. S. Stern, B. A. Horwitz: Prolactin stimulates food intake in a dose-dependent manner. Am. J. Physiol. 256 (1989) R 276-280
29. Goodall, E., C. Oxtoby, R. Richards., G. Watkinson., D. Brown, T. Silverstone: A clinical trial on the efficacy and acceptability of D-fenfluramine in the treatment of neuroleptic-induced obesity. Brit. J. Psychiat. 153 (1988) 208-213
30. Gopalaswamy, A. K., R. Morgan: Too many chronic mentally disabled patients are too fat. Acta Psychiat. Scand. 72 (1985) 254-258
31. Gordon, H. I., C. Groth: Weight change during and after hospital treatment. Arch. Gen. Psychiat. 10 (1964) 187-191
32. Green, A. I., W. A. Brown: Prolactin and neuroleptic drugs. Neurologic Clin. 6 (1988) 213-223
33. Johnson, R. D: Opioid involvement in feeding behaviour and the pathogenesis of certain eating disorders. Med. Hypot. 45 (1995) 491-497
34. Kauppila, A., P. Leinonen, R. Vihko, P. Ylöstalo: Metoclopramide-induced hyperprolactinemia impairs ovarian follicle maturation and corpus luteum function in women. J. Clin. Endocrinol. Metab. 54 (1982) 955-960
35. Kissebah, A. H., G. R. Krakover: Regional adiposity and morbidity. Physiol. Rev. 74 (1994) 761-798
36. Klett, C. J., Caffey, E. M: Weight changes during treatment with phenothiazine derivatives. J. Neuropsychiat. Nov.-Dec. (1960) 102-108
37. L'Hermite, M., J. Delogne-Desnoeck, A. Michaux-Duchene, C. Robyn: Alteration of feedback mechanism of estrogen on gonadotropin by sulpiride-induced hyperprolactinemia. J. Clin. Endocrinol. Metab. 47 (1978) 1132-1136
38. Lee Vance, M., M. O. Thorner Prolactin: hyperprolactinemic syndromes and magement. In: Wilson, J. D., D. N. Foster: Williams Textbook of Endocrinology. W. B. Saunders, Philadelphia (1992) 394-403
39. Matsuzaki, T., K. Auma, M. Irahara, T. Yasui, T. Aono: Mechanism of anovulation in hyperprolactinemic amenorrhea determined by pulsatile gonadotropin-releasing hormone injection combined with human chorionic gonadotropin. Fertil. Steril. 62 (1994) 1143-1149
40. McNatty, K. P., R. S. Sawers, A. S. McNeilly: A possible role for prolactin in control of steroid secretion by the human Graafian follicle. Nature 250 (1974) 653-655
41. Meltzer, H. Y., D. Goode, P. M. Schyve, M. Young, V. Fang: Effect of clozapine on human serum prolactin levels. Am. J. Psychiat. 136 (1979) 1550-1555
42. Moore, B. J., T. Gerardo-Gettens, B. A. Horwitz, J. S. Stern: Hyperprolactinemia stimulates food intake in the female rat. Brain. Res. Bull. 17 (1986) 563-569
43. Mroueh, A. M., T. M. Siler Khodr: Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine. J. Clin. Endocrinol. Metab. 43 (1976) 1398-1401
44. Murzi, E., T. Baptista, L. Hernández: Hypothalamic sites affecting masticatory neurons in rats. Brain Res. Bull. 26 (1991) 321-325
45. Nakano, R., T. Nishi: Progesterone feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women. Obstet. Gynecol. 73 (1989) 617-621
46. Oades, R. D., R. Schepker: Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinol. 19 (1994) 373-385
47. Olefski, J. M.: Obesity. In: K. J. Isselbacher, E. Braunwald, J. D. Wilson, J. B. Martin, A. S. Fauci, D. L. Kasper: Harrison's Principles of Internal Medicine. McGraw-Hill, Inc., New York (1992) 446-452
48. O'Rahilly, S., A. Hattersely, A. Vaag, H. Gray: Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophecy? Lancet 344 (1994) 585-589
49. Parada, M. A., L. Hernández, B. G. Hoebel: Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats. Pharmacol. Biochem. Behav. 30 (1988) 917-923
50. Parada, M. A., L. Hernández, X. Páez, T. Baptista, M. Puig de Parada, M. Quijada: Mechanism of the sulpiride-induced obesity. Pharmacol. Biochem. Behav. 33 (1989) 45-50
51. Roberts, S. R., A. S. Greenberg: The new obesity genes. Nutr. Rev. 54 (1996) 41-49
52. Scaglione, R., M. R. Averna, M. A. Dichara, C. M. Barbagallo, G. Mazzola, G. Montalto, G. Licata, A. Notarbatolo: Thyroid function and release of thyroid-stimulating hormone response and prolactin from the pituitary in obesity. J. Int. Med. Res. 19 (1991) 389-394
53. Schulz, K. D., W. Geiger, E. del Pozo, H. J. Könzig: Pattern of sexual steroids, prolactin, and gonadotropic hormones during prolactin inhibition in normally cycling women. Am. J. Obstet. Gynecol. 132 (1978) 561-566
54. Sowa, M., K. Tsuji, R. Nakano: Effects of sulpiride-induced hyperprolactinemia on human ovarian follicles during the late follicular phase. Fertil. & Steril. 46 (1986) 1032-1036
55. Wade, G. N., J. E. Schneider: Metabolic fuels and reproduction in female mammals. Neurosci. Biobehav. Rev. 16 (1992) 235-272